For Cancer, Infectious Diseases, and Neurological Diseases
About Diagnose Early
Founded by a Nobel Prize-winning team including a Stanford M.D./Ph.D., a Nobel Laureate, and a Harvard Business School/UW Madison Engineer who came together through a shared vision of improving patient outcomes with innovative and early, non-invasive detection of biomarkers for cancer, neurological diseases, and infectious diseases.
At Diagnose Early, our mission is to reduce human suffering and provide valuable healthcare insights by performing non-invasive rapid testing of patients for high demand, mass-market diseases. Our customers are large scale healthcare providers. We leverage cutting edge technology for our customers to support difficult-to-resolve healthcare conditions on a massive scale. We produce massive volumes of data that support the development of breakthrough interventional therapeutics for the diseases we diagnose.
Meet the Team
Founder & CEO
Dr. Karl-Magnus Larsson, Ph.D.
Chief Science Officer
Dr. Albert Brooks - M.D.
Dr. Christopher Lock, M.D., Ph.D.,
Alyson B. Mullen
Of The Stanford University